Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antitumor Activity
100%
Plasma Half-life
100%
Immunoglobulin Fragments
100%
Multi-domain Fusion
100%
Fragment Crystallizable
100%
Recombinant Human
33%
Clinical Application
16%
Inhibit Tumor
16%
Tumor Growth
16%
Therapeutic Potential
16%
Cell Death
16%
Inducer
16%
Cancer Treatment
16%
In Cancer
16%
Cancer Cells
16%
In Vitro Activity
16%
Clinical Trials
16%
Xenograft
16%
Chimeric Protein
16%
Cancer Prevention
16%
Liver Toxicity
16%
Anticancer Agents
16%
Protein Display
16%
Human IgG1
16%
Recombinant TRAIL
16%
Long Half-life
16%
Apo2L
16%
Xenograft Tumor Model
16%
High Specific Activity
16%
Immunology and Microbiology
TNF related apoptosis inducing ligand
100%
Antineoplastic Activity
100%
Plasma Half Life
100%
Fragment Crystallizable Region
100%
Immunoglobulin Fragment
100%
In Vitro
21%
Xenograft
14%
Cell Death
7%
Cancer Cell
7%
Immunoglobulin G1
7%
Biochemistry, Genetics and Molecular Biology
Antineoplastic Activity
100%
TRAIL
100%
Intravenous Immunoglobulin
100%
Plasma Half Life
100%
Fragment Crystallizable Region
100%
Tumor Progression
7%
Cell Death
7%
Cancer Cell
7%
Clinical Trial
7%
Chimeric Protein
7%
Anticancer
7%
Half-Life
7%